{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:51:06Z","timestamp":1789411866440,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Harm-reduction strategies are interventions designed to mitigate the adverse effects of substance use, without requiring abstinence. Evidence supports the effectiveness and efficacy of harm reduction as a broad framework for addressing illicit drug use. To ensure the implementation of these measures, Center for Alcohol and Drug Research (KORFOR) was mandated by the Norwegian Directorate of Health in 2016 to annually assess municipalities\u2019 adherence to harm-reduction guidelines. This study aims to present national trends in the distribution of harm-reduction equipment for the prevention of infectious diseases, specifically needles and syringes and smoking foil. We investigated the proportion of distributing municipalities, additional equipment distributed (naloxone, condoms and lubricants, disposable toothbrushes, and cookers, filters, disinfection swabs, sterile water, and ascorbic acid), and the population coverage. Our findings indicate an increased coverage in the distribution of harm-reduction equipment in Norway between 2016 and 2022. This positive trend demonstrates progress in addressing the negative consequences of drug use and aligns with Norwegian national strategies to mitigate drug-related harms. Future research should evaluate the effectiveness of these harm-reduction strategies and identify areas for improvement within the Norwegian context, especially related to use of opioid analgesics.<\/jats:p>","DOI":"10.1186\/s12954-025-01245-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:22:44Z","timestamp":1748571764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in distribution of harm-reduction equipment for persons who use drugs in Norway, 2016\u20132022. Archival analysis based on nationwide data collections"],"prefix":"10.1186","volume":"22","author":[{"given":"Jens Christoffer","family":"Skogen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina Natalie","family":"Gottschlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Blindheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"\u00c5rstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"6","key":"1245_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/09595230600944529","volume":"25","author":"A Ritter","year":"2006","unstructured":"Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):611\u201324.","journal-title":"Drug Alcohol Rev"},{"key":"1245_CR2","unstructured":"World Health Organization. Drug-Related Harm Reduction. 2024 [cited 2024 21\/11]; Available from: https:\/\/www.emro.who.int\/asd\/health-topics\/drug-related-harm-reduction.html"},{"issue":"1","key":"1245_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/pch\/13.1.53","volume":"13","author":"The Canadian Paediatric Society","year":"2008","unstructured":"The Canadian Paediatric Society. Harm reduction: an approach to reducing risky health behaviours in adolescents. Paediatr Child Health. 2008;13(1):53\u201360.","journal-title":"Paediatr Child Health"},{"key":"1245_CR4","doi-asserted-by":"crossref","unstructured":"Hedrich D, Hartnoll RL et al. Harm-Reduction Interventions, in Textbook of Addiction Treatment: International Perspectives, N. el-Guebaly, Editors. 2021, Springer International Publishing: Cham. pp. 757\u2013775.","DOI":"10.1007\/978-3-030-36391-8_52"},{"issue":"1","key":"1245_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drugalcdep.2013.05.022","volume":"133","author":"L Gjersing","year":"2013","unstructured":"Gjersing L, Bretteville-Jensen AL. Is opioid substitution treatment beneficial if injecting behaviour continues? Drug Alcohol Depend. 2013;133(1):121\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"1245_CR6","unstructured":"The Norwegian Government. Meld. St. 16 (1996\u20131997): Narkotikapolitikken [Parliamentary White Paper No. 16 (1996\u20131997): The Drug Policy]. 1997 [cited 2024 19\/03]; Available from: https:\/\/www.regjeringen.no\/no\/dokumenter\/st-meld-nr-16_1996-97\/id191004\/"},{"issue":"1","key":"1245_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/145507259401100101","volume":"11","author":"A Skretting","year":"1994","unstructured":"Skretting A, Ervik R, \u00d8ie KE. The aidsinformation bus in Oslo. A survey among drug users. Nordisk Alkoholtidsskrift [Nordic Alcohol Studies]. 1994;11(1):18\u201329.","journal-title":"Nordisk Alkoholtidsskrift [Nordic Alcohol Studies]"},{"key":"1245_CR8","unstructured":"Skretting A, Amundsen EJ, Bilgrei OR. Historisk oversikt over narkotika i Norge 1912\u20132022 [Historical overview of narcotics in Norway 1912\u20132022; In Norwegian only]. Drugs in Norway 2023 [cited 2024 21\/11]; Available from: https:\/\/www.fhi.no\/le\/rusmidler-og-avhengighet\/narkotikainorge\/narkotika-i-historien\/historisk-oversikt-over-narkotika-i-norge-1912-2018\/?term=#2000-2022"},{"key":"1245_CR9","unstructured":"Ministry of Health and Care Services. Lov om ordning med brukerrom for inntak av narkotika (brukerromsloven) [Injection Room Act], M.o.H.a.C. Services, Editor. 2004-present."},{"key":"1245_CR10","unstructured":"Norwegian Directorate of Health. Nasjonale faglige r\u00e5d: Hepatitt C [National Professional Guidelines: Hepatitis C]. 2019 [cited 2024 19\/03]; Available from: https:\/\/www.helsedirektoratet.no\/faglige-rad\/hepatitt-c"},{"key":"1245_CR11","unstructured":"Norwegian Directorate of Health. Nasjonal overdosestrategi [National overdose strategy]. 2019 [cited 2024 19\/03]; Available from: https:\/\/www.helsedirektoratet.no\/faglige-rad\/overdose-lokalt-forebyggende-arbeid\/bakgrunn"},{"key":"1245_CR12","unstructured":"World Health Organization. Global HIV, Hepatitis and STIs Programmes. 2022 [cited 2024 19\/03]; Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/strategies\/global-health-sector-strategies"},{"key":"1245_CR13","unstructured":"World Health Organization, Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. 2022. pp. 62\u201363."},{"key":"1245_CR14","unstructured":"Ministry of Health and Care Services. Lov om vern mot smittsomme sykdommer (smittevernloven). [Act on Control of Communicable Diseases], M.o.H.a.C. Services, Editor. 1995-present."},{"key":"1245_CR15","unstructured":"Norwegian Confederation of Addiction. Gratis, tilgjengelig brukerutstyr i alle kommuner! [Free, Accessible User Equipment in All Municipalities!]. 2018 [cited 2024 19\/03]; Available from: https:\/\/www.rusfeltet.no\/arkiv\/gratis-tilgjengelig-brukerutstyr-i-alle-kommuner"},{"key":"1245_CR16","unstructured":"Statistics Norway. 07459: Alders- og kj\u00f8nnsfordeling i kommuner, fylker og hele landets befolkning (K) 1986\u20132024 [Population across municipalities]. 2024 [cited 2024 21\/11]; Available from: https:\/\/www.ssb.no\/statbank\/table\/07459\/"},{"key":"1245_CR17","unstructured":"Center for Alcohol and Drug Research (KORFOR). Om KORFOR [Published reports]. 2024 2024\/05\/29]; Available from: https:\/\/www.helse-stavanger.no\/fag-og-forskning\/kompetansetjenester\/regionalt-kompetansesenter-for-rusmiddelforskning-i-helse-vest-korfor\/om-korfor\/"},{"key":"1245_CR18","unstructured":"The Norwegian Government. Kommunesammensl\u00e5inger i kommunereformen [Merger of municipalities in the municipal reform]. 2020 [cited 2024 19\/03]; Available from: https:\/\/www.regjeringen.no\/no\/tema\/kommuner-og-regioner\/kommunestruktur\/nye-kommuner\/id2470015\/"},{"key":"1245_CR19","unstructured":"Statistics Norway. Population. 2024."},{"key":"1245_CR20","unstructured":"StataCorp. Stata 18. Statistical software. 2023."},{"key":"1245_CR21","unstructured":"Folkehelseinstituttet. Statusrapport Om eliminasjon av hepatitt B Og C Som folkehelseproblem i Norge [Status report on the elimination of hepatitis B and C as a public health threat in Norway]. Oslo; 2023."},{"key":"1245_CR22","unstructured":"European Union Drugs Agency. Viral hepatitis elimination barometer among people who inject drugs in Europe. 2024 [cited 2024 21\/11]; Available from: https:\/\/www.euda.europa.eu\/publications\/data-factsheet\/viral-hepatitis-elimination-barometer-among-people-who-inject-drugs-in-europe_en"},{"key":"1245_CR23","volume-title":"GBD compare. Trends in Norway","author":"Institute for Health Metrics and Evaluation (IHME)","year":"2015","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD compare. Trends in Norway. IHME, University of Washington: Seattle, WA; 2015."},{"key":"1245_CR24","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD compare. Comparison of nordic countries. IHME, University of Washington: Seattle, WA; 2015."},{"key":"1245_CR25","volume-title":"H\u00f8yeste Antallet Narkotikautl\u00f8ste D\u00f8dsfall Siden 2001 [Highest number of drug-induced deaths since 2001]","author":"Norwegian Institute of Public Health","year":"2024","unstructured":"Norwegian Institute of Public Health. H\u00f8yeste Antallet Narkotikautl\u00f8ste D\u00f8dsfall Siden 2001 [Highest number of drug-induced deaths since 2001]. Norwegian Institute of Public Health: Oslo; 2024."},{"issue":"2","key":"1245_CR26","doi-asserted-by":"publisher","first-page":"e5763","DOI":"10.1002\/pds.5763","volume":"33","author":"EJ Amundsen","year":"2024","unstructured":"Amundsen EJ, et al. Patterns of filled prescriptions and the association with risk of drug-induced death. A population-based nested case-control register study. Pharmacoepidemiol Drug Saf. 2024;33(2):e5763.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1245_CR27","unstructured":"Statistics Norway. Norges 100 mest folkerike kommuner [The 100 most populous municipalities in Norway]. 2024 [cited 2024 21\/11]; Available from: https:\/\/www.ssb.no\/befolkning\/folketall\/artikler\/norges-100-mest-folkerike-kommuner"},{"key":"1245_CR28","doi-asserted-by":"crossref","unstructured":"Platt L et al. Public Health Research, in Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: an analysis of pooled data sets and economic modelling. 2017, NIHR Journals Library (National Institute of Health and Care Research): Southampton (UK).","DOI":"10.3310\/phr05050"},{"key":"1245_CR29","unstructured":"European Centre for Disease Prevention and Control. Prevention and control of infectious diseases among people who inject drugs. 2023 update. 2023 [cited 2024 21\/11]; Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/people-inject-drugs-prevention-infectious-diseases-guidance.pdf"},{"issue":"5","key":"1245_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.drugpo.2010.02.001","volume":"21","author":"L Jones","year":"2010","unstructured":"Jones L, et al. Optimal provision of needle and syringe programmes for injecting drug users: A systematic review. Int J Drug Policy. 2010;21(5):335\u201342.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1245_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1465-3362.2010.00188.x","volume":"30","author":"J MacNeil","year":"2011","unstructured":"MacNeil J, Pauly B. Needle exchange as a safe Haven in an unsafe world. Drug Alcohol Rev. 2011;30(1):26\u201332.","journal-title":"Drug Alcohol Rev"},{"key":"1245_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugpo.2005.02.004","volume":"16","author":"A Wodak","year":"2005","unstructured":"Wodak A, Cooney A. Effectiveness of sterile needle and syringe programmes. Int J Drug Policy. 2005;16:31\u201344.","journal-title":"Int J Drug Policy"},{"key":"1245_CR33","unstructured":"The Norwegian Government. Nasjonal strategi for arbeidet mot virale leverbetennelser (hepatitter) [National strategy for the prevention of viral liver infections]. 2024 [cited 2024 21\/11]; Available from: https:\/\/www.regjeringen.no\/no\/dokumenter\/nasjonal-strategi-for-arbeidet-mot-virale-leverbetennelser-hepatitter\/id2504728\/"},{"key":"1245_CR34","unstructured":"The Norwegian Government. Opptrappingsplanen for rusfeltet (2016\u20132020) [Escalation Plan for the Substance Abuse Field (2016\u20132020). 2016."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01245-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01245-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T02:22:54Z","timestamp":1748571774000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01245-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01245-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4501562\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, the data included is based on aggregated data provided by municipalities as mandated by the Norwegian Directorate of Health and official statistics available online.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}